Tufts University School of Medicine’s Master of Science in Development and Regulation of Medicines and Devices (DRMD) Program is designed for those who wish to broaden their intellectual base and enhance their career options through intensive training in the broad array of disciplines that contribute to the development and regulation of human therapeutics and medical devices.
Tufts’ DRMD Master’s Program offers breadth and detail not found in other programs, and will provide a deep and broad learning experience for students that can lead to job opportunities in the life sciences business sector. Intended for working professionals attending classes on a part-time basis in the evening, it consists of twelve credits to be completed over two academic years, including a summer session.
The Boston/Cambridge metropolitan area is an ideal location to attend this degree program, as it represents a life sciences “super cluster” with numerous large pharmaceutical, biotechnology, device, and diagnostics companies; top-ranked academic research centers; contract services provider organizations; and venture capital, intellectual property, and investment firms.
The DRMD Master’s Program is closely aligned with the activities of Tufts Center for the Study of Drug Development (CSDD), an internationally recognized and renowned academic center that develops and provides strategic information to help developers, regulators, and policy makers improve the efficiency and productivity of biomedical innovation. For nearly 40 years, Tufts CSDD has conducted scholarly analyses that address economic, scientific, legal, and political issues that affect the development and regulation of human therapeutics.